G Grimbergen, H Eijkelenkamp, U Bernchou, C Bouchart, K Brown, R Chuter, A Dunlop, P Godoy Scripes, H D Heerkens, J de Leon, S S W Ng, P B Renz, A Shessel, M P W Intven, G J Meijer
PURPOSE/OBJECTIVE(S): MR-guided SBRT with a 1.5 T MR-Linac is a relatively new therapy for pancreatic tumors with varying expertise levels. Moreover, treatment planning in the upper abdomen can be challenging as target coverage is often compromised by dosimetric constraints of abutting bowel structures. This may lead to large differences between centers in protocols, practices. To increase harmonization a worldwide consortium was founded among 1.5 T MR-Linac users. In this work we report on the outcome of the first phase within this collaboration, which is the assessment of the baseline variation between the treatment planning protocols and subsequent dose distributions...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics